42202-73-3

Usage

Uses

Used in Pharmaceutical Industry:
Cyclopentanecarbothioamide is utilized as a key intermediate in the synthesis of biologically active compounds. Its thioamide functional group allows for the creation of a wide range of pharmaceuticals with potential therapeutic effects.
Used in Agricultural Industry:
In the agricultural sector, Cyclopentanecarbothioamide serves as an intermediate in the production of pesticides. Its unique chemical properties contribute to the development of effective and targeted pest control solutions.
Used in Organic Synthesis:
As a laboratory reagent, Cyclopentanecarbothioamide is employed in various organic synthesis processes. Its thioamide group facilitates the formation of complex organic molecules, making it a valuable component in the synthesis of a diverse array of compounds.
Safety Considerations:
Given the nature of Cyclopentanecarbothioamide as a chemical compound, it is crucial to handle it with care and adhere to proper safety protocols. This includes using appropriate personal protective equipment, working in well-ventilated areas, and following guidelines for safe storage and disposal.

InChI:InChI=1/C6H11NS/c7-6(8)5-3-1-2-4-5/h5H,1-4H2,(H2,7,8)

Upstream product

• 3217-94-5 cyclopentylamide 
• 4524-93-0 Cyclopentanecarboxylic acid chloride 
• 3400-45-1 cyclopentanecarboxylic acid 

Downstream Products

• 952330-68-6 methyl 2-cyclopentyl-4-(4-phenoxyphenyl)thiazole-5-carboxylate 

Relevant academic research and scientific papers

SUBSTITUTED NICOTINIMIDE INHIBITORS OF BTK AND THEIR PREPARATION AND USE IN THE TREATMENT OF CANCER, INFLAMMATION AND AUTOIMMUNE DISEASE

Compounds of Formula I, as shown below and defined herein: and pharmaceutically acceptable salts, syntheses, intermediates, formulations, and methods of treating diseases including cancer, inflammation, and autoimmune disease mediated at least in part by Bruton's Tyrosine Kinase (BTK).

HETEROCYCLE-SUBSTITUED TETRACYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR TREATMENT OF VIRAL DISEASES

The present invention relates to novel Heterocycle-Substituted Tetracyclic Compounds of Formula (I): (I) and pharmaceutically acceptable salts thereof, wherein A, A', R 2 R 3, R 4 and R are as defined herein. The present i

THIAZOLYL-SUBSTITUED TETRACYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR TREATMENT OF VIRAL DISEASES

The present invention relates to novel Thiazolyl-Substituted Tetracyclic Compounds of Formula (I) and pharmaceutically acceptable salts thereof, wherein A, A', R2R3, R4 and R5 are as defined herein. The present

THIAZOLES, IMIDAZOLES, AND PYRAZOLES USEFUL AS INHIBITORS OF PROTEIN KINASES

The present invention relates to compounds useful as inhibitors of protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising said compounds and methods of using the compounds and the compositions in the treatment of

RETROVIRAL PROTEASE INHIBITING PIPERAZINE COMPOUNDS

Retroviral protease inhibiting compounds of the formula: STR1 are disclosed.